Clinical Trial

Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee

Study acronym: MRI
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 7, 2025 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
In this work the investigators will study the relationship between chronic musculoskeletal pain and abnormal blood flow (neovascularity) around the shoulder, hip and knee. Veterans with as history of chronic shoulder, hip or knee pain and mild/moderate joint degenerative changes will be potential study subjects. Blood flow around joints will be evaluated using perfusion magnetic resonance imaging (MRI). Participants with demonstrably abnormal blood flow around their painful joint will be eligible for enrollment in a pilot study of joint embolization to treat their pain. Participants who choose to not undergo treatment will be re-assessed with MRI after one year to characterize the natural history of joint neovascularity and its relationship to pain.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-01-17; most recent amendment 2025-08-04.
Status change: Not Yet Recruiting → Recruiting 2024-10-29
Trial Details
NCT Number NCT05700682
Lead Sponsor Palo Alto Veterans Institute for Research
Collaborators: Varian Medical Systems
Conditions Osteoarthritis, Knee, Osteoarthritis, Hip, Osteo Arthritis Shoulders, Synovitis of Knee, Synovitis/Tenosynovitis - Hip, Synovitis, Pain, Chronic
Enrollment 120 participants
Start Date 2023-07-15
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-07